quinapril has been researched along with Arterial Occlusive Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H; Prior, BM; Ren, J; Yang, HT | 1 |
| Hori, M; Hoshida, S; Kawahara, K; Kuzuya, T; Yamashita, N | 1 |
2 other study(ies) available for quinapril and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Angiotensin converting enzyme inhibition enhances collateral artery remodeling in rats with femoral artery occlusion.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arterial Occlusive Diseases; Blood Flow Velocity; Blood Pressure; Collateral Circulation; Dose-Response Relationship, Drug; Femoral Artery; Gene Expression; Heart Rate; Hindlimb; Male; Muscle, Skeletal; Nitric Oxide Synthase Type III; Peptidyl-Dipeptidase A; Quinapril; Random Allocation; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrahydroisoquinolines; Vascular Endothelial Growth Factor A | 2008 |
Amelioration by quinapril of myocardial infarction induced by coronary occlusion/reperfusion in a rabbit model of atherosclerosis: possible mechanisms.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arterial Occlusive Diseases; Coronary Artery Disease; Cyclic GMP; Disease Models, Animal; Enzyme Inhibitors; Hemodynamics; Isoquinolines; Leukocytes; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; P-Selectin; Peroxidase; Quinapril; Rabbits; Receptor, Bradykinin B2; Receptors, Bradykinin; Tetrahydroisoquinolines; Ventricular Fibrillation | 1999 |